Four Decades for Justice
Cravath’s broad‑based intellectual property practice has deep experience advising clients ranging from early‑stage startups to global companies in corporate contexts across the full spectrum of intellectual property disciplines, technologies and jurisdictions. Our corporate IP practice is distinctive for its “cross‑disciplinary and highly collaborative approach,” placing Cravath “a class apart” for providing “integrated solutions to the most pressing legal and business problems faced by industry leaders.” (IAM Patent 1000)
Cravath’s IP lawyers work hand in glove with our premier M&A team to handle the many intellectual property issues that arise in complex transactions, including issues relating to patents, trademarks, copyrights, data, trade secrets, privacy and information security. We also advise on matters in connection with emerging technologies, including artificial intelligence and blockchain.
Our IP lawyers bring a great depth of technical and scientific backgrounds to provide expert advice related to:
Cravath also provides strategic counseling, review and analysis in developing and managing intellectual property portfolios, commercializing innovation‑based assets and optimizing intellectual property rights to ensure our clients are maximizing value from their intellectual property in the U.S. and in non-U.S. markets.
Cravath helps clients navigate AI and data issues with respect to data ownership and licensing, business operations and disputes related to AI and data, as well as the acquisition of data and AI technologies. Our expertise across subject areas allows us to provide interdisciplinary advice on AI and data issues, including ownership of and rights to use AI algorithms and related data, confidentiality management and related transaction structuring.
Cravath advises on a wide variety of data security and privacy issues across the whole spectrum of transactions and projects, including data collection, data storage, multi‑party data arrangements and agreements, such as between data controllers and/or data processors, cross‑border data‑sharing, protection of personally identifiable and other sensitive information, and privacy and data protection compliance matters, including advising on privacy policies and privacy notices and other privacy compliance requirements under the GDPR and other relevant regimes.
Cravath’s IP lawyers work hand in glove with our premier M&A team to handle the many intellectual property issues that arise in complex transactions, including issues relating to patents, trademarks, copyrights, data, trade secrets, privacy and information security. We also advise on matters in connection with emerging technologies, including artificial intelligence and blockchain.
Our IP lawyers bring a great depth of technical and scientific backgrounds to provide expert advice related to:
Cravath also provides strategic counseling, review and analysis in developing and managing intellectual property portfolios, commercializing innovation‑based assets and optimizing intellectual property rights to ensure our clients are maximizing value from their intellectual property in the U.S. and in non-U.S. markets.
Cravath helps clients navigate AI and data issues with respect to data ownership and licensing, business operations and disputes related to AI and data, as well as the acquisition of data and AI technologies. Our expertise across subject areas allows us to provide interdisciplinary advice on AI and data issues, including ownership of and rights to use AI algorithms and related data, confidentiality management and related transaction structuring.
Cravath advises on a wide variety of data security and privacy issues across the whole spectrum of transactions and projects, including data collection, data storage, multi‑party data arrangements and agreements, such as between data controllers and/or data processors, cross‑border data‑sharing, protection of personally identifiable and other sensitive information, and privacy and data protection compliance matters, including advising on privacy policies and privacy notices and other privacy compliance requirements under the GDPR and other relevant regimes.
Deals & Cases
September 19, 2023
On September 19, 2023, affiliates of private investment firm Lindsay Goldberg, in partnership with the company’s management, announced the completion of an investment in The Kleinfelder Group, a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
September 18, 2023
On September 18, 2023, OMERS Private Equity announced the signing of a definitive agreement to acquire a majority stake in Knight Commercial, a leading provider of commercial restoration services. Cravath is representing OMERS Private Equity in connection with the transaction.
Deals & Cases
September 14, 2023
On September 11, 2023, Bacardi Limited (“Bacardi”), the largest privately held international spirits company in the world, announced the completion of a transaction that makes the family‑owned company the sole owner of ILEGAL Mezcal®, a leading super premium artisanal mezcal. Cravath is representing Bacardi in connection with the transaction.
Deals & Cases
August 15, 2023
On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.
Deals & Cases
August 10, 2023
On August 10, 2023, Forward Air Corporation (“Forward”), a provider of transportation services, and Omni Logistics, LLC (“Omni”), a private logistics and supply chain management company that is majority owned by Ridgemont Equity Partners and EVE Partners, LLC, announced that they have entered into a definitive agreement under which Forward and Omni will combine in a cash-and-stock transaction, creating a combined company that generated approximately $3.7 billion of combined company adjusted revenue for the twelve months ended June 30, 2023. Cravath is representing Forward in connection with the transaction.
Activities & Publications
September 20, 2023
On September 19, 2023, Cravath partner David J. Kappos participated in IAM Connect’s SEP Summit 2023, which was held virtually from September 19‑21, 2023. Dave spoke on a panel entitled “The game‑changing European SEP/FRAND draft regulation,” which reviewed the potential impacts of a recent policy proposed in Brussels to create a SEP royalty rate setting body in Europe’s trademark office, including the practical impact on licensors in Europe, how SEP owners will need to adapt and implications for global SEP strategy.
Activities & Publications
September 07, 2023
Cravath partner Sasha Rosenthal‑Larrea and associates Daniel M. Barabander and Leslie Liu co‑authored an article entitled “Understanding China’s Crypto‑Blockchain Dichotomy,” which was published to the website of Law360 on September 6, 2023. The article discusses China’s “nuanced and complicated” approach to crypto‑related technology, examining its efforts to restrict cryptocurrency use while supporting blockchain as a complementary technology to real economy sectors.
Activities & Publications
September 06, 2023
Cravath partner David J. Kappos, associate Carys J. Webb and Shawn Muma, Director of Supply Chain Innovation and Emerging Technologies for the Center for Global Enterprise’s Digital Supply Chain Institute, co‑authored an article entitled “The Data‑Driven Supply Chain Raises New Data Governance and Security Issues,” which was published in the September/October 2023 issue of Supply Chain Management Review. The article examines the growing role of data sharing in supply chain constellations and recommends that companies embed data governance and security policies in their internal and external supply chain operations.
Accolades
August 21, 2023
On August 17, 2023, Cravath’s Evan R. Chesler, David J. Kappos and Faiza J. Saeed were each named 2024 “Lawyers of the Year” for New York City in their respective practice areas by The Best Lawyers in America. Evan was recognized for ERISA Litigation, Dave was recognized for Patent Law and Faiza was recognized for International Mergers and Acquisitions. The awards honor individuals with the highest overall peer feedback for a practice area and within a geographic market.
Activities & Publications
July 11, 2023
On June 15, 2023, Cravath partner David J. Kappos spoke at “Science in the City,” an event that is part of Johnson & Johnson Innovation’s JLABS program in New York. Dave spoke on a panel which reviewed the recent landscape of innovation in New York, including how it continues to thrive and some of the unique benefits of innovating in the city.
Deals & Cases
September 19, 2023
On September 19, 2023, affiliates of private investment firm Lindsay Goldberg, in partnership with the company’s management, announced the completion of an investment in The Kleinfelder Group, a leading engineering, design, construction management, construction materials inspection and testing, and environmental professional services firm. Cravath is representing Lindsay Goldberg in connection with the transaction.
Deals & Cases
September 18, 2023
On September 18, 2023, OMERS Private Equity announced the signing of a definitive agreement to acquire a majority stake in Knight Commercial, a leading provider of commercial restoration services. Cravath is representing OMERS Private Equity in connection with the transaction.
Deals & Cases
September 14, 2023
On September 11, 2023, Bacardi Limited (“Bacardi”), the largest privately held international spirits company in the world, announced the completion of a transaction that makes the family‑owned company the sole owner of ILEGAL Mezcal®, a leading super premium artisanal mezcal. Cravath is representing Bacardi in connection with the transaction.
Deals & Cases
August 15, 2023
On August 14, 2023, DRI Healthcare Trust, a global leader in providing financing to advance innovation in the life sciences industry, managed by DRI Capital Inc., announced that it has purchased a second royalty interest in the worldwide net sales of ORSERDU®, the first approved targeted therapy used in the treatment of postmenopausal women or adult men with advanced or metastatic breast cancer who have experienced disease progression despite prior endocrine therapy. DRI Healthcare entered into a purchase agreement with Radius Pharmaceuticals, Inc., a wholly owned subsidiary of Radius Health, Inc. for an upfront purchase price of $130 million. In addition to running royalties, DRI Healthcare is also entitled to receive milestone payments of up to $40 million on the achievement of sales performance thresholds. Cravath represented DRI Capital Inc. in connection with the transaction.
Deals & Cases
August 10, 2023
On August 10, 2023, Forward Air Corporation (“Forward”), a provider of transportation services, and Omni Logistics, LLC (“Omni”), a private logistics and supply chain management company that is majority owned by Ridgemont Equity Partners and EVE Partners, LLC, announced that they have entered into a definitive agreement under which Forward and Omni will combine in a cash-and-stock transaction, creating a combined company that generated approximately $3.7 billion of combined company adjusted revenue for the twelve months ended June 30, 2023. Cravath is representing Forward in connection with the transaction.
Activities & Publications
September 20, 2023
On September 19, 2023, Cravath partner David J. Kappos participated in IAM Connect’s SEP Summit 2023, which was held virtually from September 19‑21, 2023. Dave spoke on a panel entitled “The game‑changing European SEP/FRAND draft regulation,” which reviewed the potential impacts of a recent policy proposed in Brussels to create a SEP royalty rate setting body in Europe’s trademark office, including the practical impact on licensors in Europe, how SEP owners will need to adapt and implications for global SEP strategy.
Activities & Publications
September 07, 2023
Cravath partner Sasha Rosenthal‑Larrea and associates Daniel M. Barabander and Leslie Liu co‑authored an article entitled “Understanding China’s Crypto‑Blockchain Dichotomy,” which was published to the website of Law360 on September 6, 2023. The article discusses China’s “nuanced and complicated” approach to crypto‑related technology, examining its efforts to restrict cryptocurrency use while supporting blockchain as a complementary technology to real economy sectors.
Activities & Publications
September 06, 2023
Cravath partner David J. Kappos, associate Carys J. Webb and Shawn Muma, Director of Supply Chain Innovation and Emerging Technologies for the Center for Global Enterprise’s Digital Supply Chain Institute, co‑authored an article entitled “The Data‑Driven Supply Chain Raises New Data Governance and Security Issues,” which was published in the September/October 2023 issue of Supply Chain Management Review. The article examines the growing role of data sharing in supply chain constellations and recommends that companies embed data governance and security policies in their internal and external supply chain operations.
Accolades
August 21, 2023
On August 17, 2023, Cravath’s Evan R. Chesler, David J. Kappos and Faiza J. Saeed were each named 2024 “Lawyers of the Year” for New York City in their respective practice areas by The Best Lawyers in America. Evan was recognized for ERISA Litigation, Dave was recognized for Patent Law and Faiza was recognized for International Mergers and Acquisitions. The awards honor individuals with the highest overall peer feedback for a practice area and within a geographic market.
Activities & Publications
July 11, 2023
On June 15, 2023, Cravath partner David J. Kappos spoke at “Science in the City,” an event that is part of Johnson & Johnson Innovation’s JLABS program in New York. Dave spoke on a panel which reviewed the recent landscape of innovation in New York, including how it continues to thrive and some of the unique benefits of innovating in the city.
Explore
Celebrating 200 years of partnership. In 2019, we celebrated our bicentennial. Our history mirrors that of our nation. Integral to our story is our culture.
Attorney Advertising. © 2023 Cravath, Swaine & Moore LLP.